Open Government Portal

Found 10 records similar to May 27, 2020 – Appearance by the Minister of National Defence

Provincial

As of June 16, all COVID-19 datasets will be updated weekly on Thursdays by 2pm. This dataset details the percentage of COVID-19 positive patients in hospitals and ICUs for COVID-19 related reasons, and for reasons other than COVID-19. Data includes: * reporting date * percentage of COVID-19 positive patients in hospital admitted for COVID-19 * percentage of COVID-19 positive patients in hospital admitted for other reasons * percentage of COVID-19 positive patients in ICU admitted for COVID-19 * percentage of COVID-19 positive patients in ICU admitted for other reasons Due to incomplete weekend and holiday reporting, data for hospital and ICU admissions are not updated on Sundays, Mondays and the day after holidays. This dataset is subject to change.

Last Updated: Nov. 30, 2022
Date Published: Jan. 11, 2022
Organization: Government of Ontario
Formats: CSV HTML
Keywords:  COVID-19, Health, Health and wellness
Federal

COVID-19 is a new disease not previously identified in humans. Currently there is no vaccine or therapeutic product for COVID-19 that is authorized to treat or prevent the disease. The outbreak of COVID-19 has resulted in a global review of therapies that could be used to treat or prevent the infection. In an effort to facilitate earlier access to a vaccine, or therapeutic product for COVID-19, the Department will expedite the review of any COVID-19 related health product submissions and applications.

Last Updated: Apr. 7, 2020
Date Published: Apr. 3, 2020
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19 outbreak, pandemic, vaccine for COVID-19, health product submissions and applications
Federal

Briefing binder created for the Minister of National Defence on the occasion of his appearance before the Special Committee on the COVID-19 Pandemic on May 5. Includes Canadian Armed Forces Support to the Whole-of-Government, Response to COVID-19, Canadian Armed Forces assistance to Long Term Care Facilities, HMCS Fredericton Helicopter Accident, Parliamentary Budget Officer costing of Class C employment for Op Laser, Countering Misinformation on COVID-19

Last Updated: Sep. 3, 2020
Date Published: Sep. 1, 2020
Organization: National Defence
Formats: HTML
Keywords:  Canadian Armed Forces Support to the Whole-of-Government Response to COVID-19, Canadian Armed Forces assistance to Long Term Care Facilities, HMCS Fredericton Helicopter Accident, Parliamentary Budget Officer costing of Class C employment for Op Laser, Countering Misinformation on COVID-19
Provincial

*As of June 16, all COVID-19 datasets will be updated weekly on Thursdays by 2pm. * This dataset reports the daily reported number of deaths involving COVID-19 by fatality type. Learn how the Government of Ontario is helping to keep Ontarians safe during the 2019 Novel Coronavirus outbreak. Data include: * Reporting date of the deaths involving COVID-19 * Total number of deaths involving COVID-19 * Number of deaths with “COVID-19 as the underlying cause of death” * Number of deaths with “COVID-19 contributed but not underlying cause” * Number of deaths where the “Cause of death unknown” or “Cause of death missing” ##Additional Notes * Data are based on net change in COVID-19 deaths for which COVID-19 caused the death reported day over day.

Last Updated: Nov. 30, 2022
Date Published: Mar. 9, 2022
Organization: Government of Ontario
Formats: XLSX CSV HTML
Keywords:  COVID-19, health, deaths
Federal

Variant strains of SARS-CoV-2 are emerging that may affect the level of protection provided by currently authorized COVID-19 vaccines. As a result, manufacturers are adapting authorized COVID-19 vaccines to provide protection against infection and disease caused by virus variants.

Last Updated: Jul. 27, 2021
Date Published: Mar. 26, 2021
Organization: Health Canada
Formats: HTML
Keywords:  coronavirus, COVID-19, pandemic, drugs, medications, vaccines, market authorization, licensing, importing or selling
Federal

COVID-19 is a new disease. A vaccine or therapy to treat or prevent this disease has not yet been developed. However, the COVID-19 pandemic has resulted in a global review of therapies that may be used to treat or prevent the disease. Canada is speeding up the importation and sale of medical devices used to diagnose, treat or prevent COVID-19.

Last Updated: Apr. 7, 2020
Date Published: Apr. 2, 2020
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, COVID-19 pandemic, importation and sale of medical devices, diagnose, treat or prevent COVID-19, list of COVID-19 Diagnostic Device.
Federal

What being vaccinated against COVID-19 means for me. By getting vaccinated, you benefit from the protection you get against COVID-19 and the easing of restrictive measures in your community.

Last Updated: Aug. 23, 2021
Date Published: Jun. 25, 2021
Organization: Public Health Agency of Canada
Formats: PDF HTML
Keywords:  being vaccinated, against COVID-19, means for me, getting vaccinated, benefit from the protection, protection, against COVID-19, COVID-19, coronavirus
Federal

The purpose of this document is to assist in planning immunization clinics for COVID-19 vaccines during the COVID-19 pandemic.

Last Updated: Jan. 25, 2021
Date Published: Dec. 12, 2020
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  COVID-19, Coronavirus, clinic planning, leadership, coordination, immunization, clinic, human resources, communications
Federal

People with COVID-19 do not always recognize their early symptoms. Even if you do not have symptoms now, it is possible to transmit COVID-19 before you start showing symptoms or without ever developing symptoms. You need to quarantine (self-isolate) for 14 days at home when you may have been exposed to COVID-19 and have no symptoms. Quarantine and isolation can help to prevent the spread of COVID-19 to others.

Last Updated: Nov. 3, 2021
Date Published: May 1, 2020
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  COVID-19, isolation, symptoms, recovery, emergency, measures, unvaccinated, asymptomatic, Quarantine Act
Federal

The medicine regulators from Australia, Canada, Singapore, Switzerland and the United Kingdom (Access Consortium) have discussed the regulatory evidence requirements for COVID-19 vaccine approvals and considerations for post-market pharmacovigilance. This collective statement on COVID-19 vaccines builds on the Consortium's May 2020 pledge to work together to counter the COVID-19 global pandemic.

Last Updated: Jun. 30, 2021
Date Published: Jan. 21, 2021
Organization: Health Canada
Formats: HTML
Keywords:  coronavirus, COVID-19, vaccines, international, medications, drugs, biologics, Health Canada
Date modified: